From the diagnosis and execution of the asset valuation process, to the conclusion of the business and consequent follow-up.
Whether you’re looking to sell, acquire, or optimize the performance of a mid-market company, there’s truly only one place you can turn to for reliably superior results: ELS Solutions Group.
Our differentiation
A customer-oriented organization, focused on deeply understanding our client’s unique needs and critical mission objectives.
When you decide to engage with the ELS Solutions Group, you are involving a cutting-edge organization equipped with resources, where your dedicated M&A Advisor serves as an organizational maestro, directing and coordinating action plans that take you where you want to go.
Our approach
1. Technical Focus
We go beyond financial perspectives, as we are experts in financial and pharmaceutical health. We blend a unique set of attributes and competencies with a high level of scientific excellence, backed by decades of experience in the pharmaceutical, MedTech, and healthcare industries. With combined PhDs and MBAs, ELS Solutions Group offers a unique set of insights to help you materialize your venture safely and pragmatically.
2. Personalized
Every engagement is unique and requires a tailored approach. Our philosophy is all about personalized client service and professionals you can trust to act solely in the best interest of our client.
3. Confidential
We are extremely stringent in protecting the confidentiality of our clients’ business initiatives and their information, which we guard with the utmost vigilance.
4. Valuation
We further focus on helping our clients fully and intelligently understand the dynamics of value and company valuation to eliminate guesswork and unrealistic expectations.
5. Results-Oriented
In our practice, we adopt an honest, transparent, and collaborative approach, characterized by a professional partnership. Our tendency is to set modest commitments and exceed expectations in delivering results.
6. Client and People-Centered
Where the world of mergers and acquisitions sometimes focuses on revenues, EBITDA multiples, compound annual growth rates, which are important and serve their purpose, ELS Solutions Group understands it’s truly about people, their pride in what they’ve built, their underlying motives, and what they truly strive to achieve.
7. Clear and Action-Oriented
We listen and understand our clients’ goals, concerns, sensitivities, vision, and prioritized objectives. We simplify the complex. We cooperatively share our experience and wisdom gained over the years to provide fresh and objective insights and advice. We formulate sensible strategic action plans carefully aligned with our clients’ objectives. Then, we mobilize a coordinated effort – leveraging technology and working in harmony to firmly achieve our clients’ objectives without compromise in the pharmaceutical, MedTech, dietary supplements, and healthcare sectors.
Our methodology
Our methodology includes:
National and international research;
Application of our combined scientific and financial know-how in asset valuation, incorporating both financial and non-financial criteria important to the pharmaceutical industry (we go beyond EBITDA):
Technical assessment:
- Post-registration asset assessment and registration asset assessment;
- Site and facility assessment;
- QMS assessment;
- Pipeline assessment;
- And many others.
Implementation of assessment, teasers, management presentations, books, VDD, preliminary and confirmatory due diligence, as well as legal, tax, and regulatory validation with business monitoring until its completion.
